Gebruikersprofielen voor "Verhoef, J. "
 | Jan Verhoefem hoogleraar Besmettingsleer University Utrecht Geverifieerd e-mailadres voor worldhealthcareforum.com Geciteerd door 43754 |
Streptococcus pneumoniae: virulence factors, pathogenesis, and vaccines
E AlonsoDeVelasco, AF Verheul, J Verhoef… - Microbiological …, 1995 - Am Soc Microbiol
Although pneumococcal conjugate vaccines are close to being licensed, a more profound
knowledge of the virulence factors responsible for the morbidity and mortality caused by …
knowledge of the virulence factors responsible for the morbidity and mortality caused by …
Chitosan and its derivatives in mucosal drug and vaccine delivery
IM Van der Lubben, JC Verhoef, G Borchard… - European Journal of …, 2001 - Elsevier
Numerous studies have demonstrated that chitosan and their derivatives (N-trimethyl chitosan,
mono-N-carboxymethyl chitosan) are effective and safe absorption enhancers to improve …
mono-N-carboxymethyl chitosan) are effective and safe absorption enhancers to improve …
Nasal mucociliary clearance as a factor in nasal drug delivery
E Marttin, NGM Schipper, JC Verhoef… - Advanced drug delivery …, 1998 - Elsevier
The nasal mucociliary clearance system transports the mucus layer that covers the nasal
epithelium towards the nasopharynx by ciliary beating. Its function is to protect the respiratory …
epithelium towards the nasopharynx by ciliary beating. Its function is to protect the respiratory …
Emerging Importance of Multidrug-Resistant Acinetobacter Species and Stenotrophomonas maltophilia as Pathogens in Seriously Ill Patients: Geographic Patterns …
As part of the SENTRY Antimicrobial Surveillance Program, a total of 1078 Acinetobacter
species and 842 Stenotrophomonas maltophilia isolates were collected between January 1997 …
species and 842 Stenotrophomonas maltophilia isolates were collected between January 1997 …
Molecular typing of methicillin-resistantStaphylococcus aureus on the basis of protein A gene polymorphism
HME Frenay, AE Bunschoten, LM Schouls… - European Journal of …, 1996 - Springer
… Vandenbroucke-Grauls CM, Fr~nay HME, van Kiingeren B, Savelkoul TF, Verhoef J:
Control of epidemic methicillin-resistant Staphylococcus aureus in a Dutch university hospital. …
Control of epidemic methicillin-resistant Staphylococcus aureus in a Dutch university hospital. …
Preparation and NMR characterization of highly substitutedN-trimethyl chitosan chloride
N,N,N-Trimethyl chitosan chloride (TMC) is a chemically modified chitosan with improved
aqueous solubility, compared with the native chitosan. It is essential to follow a synthesis …
aqueous solubility, compared with the native chitosan. It is essential to follow a synthesis …
Epidemiology and Susceptibility of 3,051Staphylococcus aureus Isolates from 25 University Hospitals Participating in the European SENTRY Study
AC Fluit, CLC Wielders, J Verhoef… - Journal of clinical …, 2001 - Am Soc Microbiol
A total of 3,051 methicillin-susceptible Staphylococcus aureus (MSSA) isolates and
methicillin-resistant S. aureus (MRSA) isolates in Europe were compared. MRSA isolates constituted …
methicillin-resistant S. aureus (MRSA) isolates in Europe were compared. MRSA isolates constituted …
Oral drug absorption enhancement by chitosan and its derivatives
M Thanou, JC Verhoef, HE Junginger - Advanced drug delivery reviews, 2001 - Elsevier
Chitosan is a non-toxic, biocompatible polymer that has found a number of applications in
drug delivery including that of absorption enhancer of hydrophilic macromolecular drugs. …
drug delivery including that of absorption enhancer of hydrophilic macromolecular drugs. …
The potential of mucoadhesive polymers in enhancing intestinal peptide drug absorption. III: Effects of chitosan-glutamate and carbomer on epithelial tight junctions in …
G Borchard, HL Lueβen, AG de Boer… - Journal of controlled …, 1996 - Elsevier
Two mucoadhesive polymers, chitosan-glutamate and carbomer, were studied in an in vitro
model (Caco-2 cell monolayers) with respect to their ability to enhance intestinal peptide …
model (Caco-2 cell monolayers) with respect to their ability to enhance intestinal peptide …
Prognostic values of tumor necrosis factor/cachectin, interleukin-l, interferon-α, and interferon-γ in the serum of patients with septic shock
T Calandra, JD Baumgartner, GE Grau… - Journal of Infectious …, 1990 - academic.oup.com
Serum concentrations of immunoreactive tumor necrosis factor/cachectin (TNF), interleukin-1β
(IL-1β), interferon-γ (IFNγ, and interferon-α (IFNα) were prospectively measured in 70 …
(IL-1β), interferon-γ (IFNγ, and interferon-α (IFNα) were prospectively measured in 70 …